Cargando…

Global analysis of genetic circuitry and adaptive mechanisms enabling resistance to the azole antifungal drugs

Invasive fungal infections caused by the pathogen Candida albicans have transitioned from a rare curiosity to a major cause of human mortality. This is in part due to the emergence of resistance to the limited number of antifungals available to treat fungal infections. Azoles function by targeting t...

Descripción completa

Detalles Bibliográficos
Autores principales: Mount, Harley O’Connor, Revie, Nicole M., Todd, Robert T., Anstett, Kaitlin, Collins, Cathy, Costanzo, Michael, Boone, Charles, Robbins, Nicole, Selmecki, Anna, Cowen, Leah E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5922528/
https://www.ncbi.nlm.nih.gov/pubmed/29702647
http://dx.doi.org/10.1371/journal.pgen.1007319
_version_ 1783318213061246976
author Mount, Harley O’Connor
Revie, Nicole M.
Todd, Robert T.
Anstett, Kaitlin
Collins, Cathy
Costanzo, Michael
Boone, Charles
Robbins, Nicole
Selmecki, Anna
Cowen, Leah E.
author_facet Mount, Harley O’Connor
Revie, Nicole M.
Todd, Robert T.
Anstett, Kaitlin
Collins, Cathy
Costanzo, Michael
Boone, Charles
Robbins, Nicole
Selmecki, Anna
Cowen, Leah E.
author_sort Mount, Harley O’Connor
collection PubMed
description Invasive fungal infections caused by the pathogen Candida albicans have transitioned from a rare curiosity to a major cause of human mortality. This is in part due to the emergence of resistance to the limited number of antifungals available to treat fungal infections. Azoles function by targeting the biosynthesis of ergosterol, a key component of the fungal cell membrane. Loss-of-function mutations in the ergosterol biosynthetic gene ERG3 mitigate azole toxicity and enable resistance that depends upon fungal stress responses. Here, we performed a genome-wide synthetic genetic array screen in Saccharomyces cerevisiae to map ERG3 genetic interactors and uncover novel circuitry important for azole resistance. We identified nine genes that enabled erg3-mediated azole resistance in the model yeast and found that only two of these genes had a conserved impact on resistance in C. albicans. Further, we screened a C. albicans homozygous deletion mutant library and identified 13 genes for which deletion enhances azole susceptibility. Two of the genes, RGD1 and PEP8, were also important for azole resistance acquired by diverse mechanisms. We discovered that loss of function of retrograde transport protein Pep8 overwhelms the functional capacity of the stress response regulator calcineurin, thereby abrogating azole resistance. To identify the mechanism through which the GTPase activator protein Rgd1 enables azole resistance, we selected for mutations that restore resistance in strains lacking Rgd1. Whole genome sequencing uncovered parallel adaptive mechanisms involving amplification of both chromosome 7 and a large segment of chromosome 3. Overexpression of a transporter gene on the right portion of chromosome 3, NPR2, was sufficient to enable azole resistance in the absence of Rgd1. Thus, we establish a novel mechanism of adaptation to drug-induced stress, define genetic circuitry underpinning azole resistance, and illustrate divergence in resistance circuitry over evolutionary time.
format Online
Article
Text
id pubmed-5922528
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-59225282018-05-11 Global analysis of genetic circuitry and adaptive mechanisms enabling resistance to the azole antifungal drugs Mount, Harley O’Connor Revie, Nicole M. Todd, Robert T. Anstett, Kaitlin Collins, Cathy Costanzo, Michael Boone, Charles Robbins, Nicole Selmecki, Anna Cowen, Leah E. PLoS Genet Research Article Invasive fungal infections caused by the pathogen Candida albicans have transitioned from a rare curiosity to a major cause of human mortality. This is in part due to the emergence of resistance to the limited number of antifungals available to treat fungal infections. Azoles function by targeting the biosynthesis of ergosterol, a key component of the fungal cell membrane. Loss-of-function mutations in the ergosterol biosynthetic gene ERG3 mitigate azole toxicity and enable resistance that depends upon fungal stress responses. Here, we performed a genome-wide synthetic genetic array screen in Saccharomyces cerevisiae to map ERG3 genetic interactors and uncover novel circuitry important for azole resistance. We identified nine genes that enabled erg3-mediated azole resistance in the model yeast and found that only two of these genes had a conserved impact on resistance in C. albicans. Further, we screened a C. albicans homozygous deletion mutant library and identified 13 genes for which deletion enhances azole susceptibility. Two of the genes, RGD1 and PEP8, were also important for azole resistance acquired by diverse mechanisms. We discovered that loss of function of retrograde transport protein Pep8 overwhelms the functional capacity of the stress response regulator calcineurin, thereby abrogating azole resistance. To identify the mechanism through which the GTPase activator protein Rgd1 enables azole resistance, we selected for mutations that restore resistance in strains lacking Rgd1. Whole genome sequencing uncovered parallel adaptive mechanisms involving amplification of both chromosome 7 and a large segment of chromosome 3. Overexpression of a transporter gene on the right portion of chromosome 3, NPR2, was sufficient to enable azole resistance in the absence of Rgd1. Thus, we establish a novel mechanism of adaptation to drug-induced stress, define genetic circuitry underpinning azole resistance, and illustrate divergence in resistance circuitry over evolutionary time. Public Library of Science 2018-04-27 /pmc/articles/PMC5922528/ /pubmed/29702647 http://dx.doi.org/10.1371/journal.pgen.1007319 Text en © 2018 Mount et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Mount, Harley O’Connor
Revie, Nicole M.
Todd, Robert T.
Anstett, Kaitlin
Collins, Cathy
Costanzo, Michael
Boone, Charles
Robbins, Nicole
Selmecki, Anna
Cowen, Leah E.
Global analysis of genetic circuitry and adaptive mechanisms enabling resistance to the azole antifungal drugs
title Global analysis of genetic circuitry and adaptive mechanisms enabling resistance to the azole antifungal drugs
title_full Global analysis of genetic circuitry and adaptive mechanisms enabling resistance to the azole antifungal drugs
title_fullStr Global analysis of genetic circuitry and adaptive mechanisms enabling resistance to the azole antifungal drugs
title_full_unstemmed Global analysis of genetic circuitry and adaptive mechanisms enabling resistance to the azole antifungal drugs
title_short Global analysis of genetic circuitry and adaptive mechanisms enabling resistance to the azole antifungal drugs
title_sort global analysis of genetic circuitry and adaptive mechanisms enabling resistance to the azole antifungal drugs
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5922528/
https://www.ncbi.nlm.nih.gov/pubmed/29702647
http://dx.doi.org/10.1371/journal.pgen.1007319
work_keys_str_mv AT mountharleyoconnor globalanalysisofgeneticcircuitryandadaptivemechanismsenablingresistancetotheazoleantifungaldrugs
AT revienicolem globalanalysisofgeneticcircuitryandadaptivemechanismsenablingresistancetotheazoleantifungaldrugs
AT toddrobertt globalanalysisofgeneticcircuitryandadaptivemechanismsenablingresistancetotheazoleantifungaldrugs
AT anstettkaitlin globalanalysisofgeneticcircuitryandadaptivemechanismsenablingresistancetotheazoleantifungaldrugs
AT collinscathy globalanalysisofgeneticcircuitryandadaptivemechanismsenablingresistancetotheazoleantifungaldrugs
AT costanzomichael globalanalysisofgeneticcircuitryandadaptivemechanismsenablingresistancetotheazoleantifungaldrugs
AT boonecharles globalanalysisofgeneticcircuitryandadaptivemechanismsenablingresistancetotheazoleantifungaldrugs
AT robbinsnicole globalanalysisofgeneticcircuitryandadaptivemechanismsenablingresistancetotheazoleantifungaldrugs
AT selmeckianna globalanalysisofgeneticcircuitryandadaptivemechanismsenablingresistancetotheazoleantifungaldrugs
AT cowenleahe globalanalysisofgeneticcircuitryandadaptivemechanismsenablingresistancetotheazoleantifungaldrugs